Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1 hsp>ng/ml following prostatectomy: How much information can conventional imaging provide?
详细信息 查看全文
- 作者：Hebert Alberto Vargas ; M.D.a ; vargasah@mskcc.org" class="auth_mail" title="E-mail the corresponding author ; Alexandre G. Martin-Malburet ; M.D.b ; Toshikazu Takeda ; M.D.b ; Renato B. Corradi ; M.D.b ; James Eastham ; M.D.b ; Andreas Wibmer ; M.D.a ; Evis Sala ; M.D. ; Ph.D.a ; Michael J. Zelefsky ; M.D.c ; Wolfgang A. Weber ; M.D. ; Ph.D.a ; Hedvig Hricak ; M.D. ; Ph.D.a
- 关键词：Bone scan ; CT ; MRI ; PET ; Prostate cancer ; Recurrence
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：34
- 期：11
- 页码：482.e5-482.e10
- 全文大小：412 K
文摘
- •
Pelvic MRI was positive in 15/142 (11%) patients.
- •
Overall, 14/15 patients had local recurrence and 1/15 had osseous metastases.
- •
No patient with a negative pelvic MRI had metastases on other imaging examinations.